Global University Venturing

NEA has led a series B round for cancer treatment developer Pionyr Immunotherapeutics, co-founded by researchers from UC San Francisco and University of Toronto.

Satt Sud-Est has licensed technology relating to metamaterial-based antennae for very powerful MRI scanners to Multiwave Innovation.

VTT spinout TactoTek has attracted $5.9m in funding from Ascend Capital Partners.

The ocular biotech spinout was has received cash from backers including the VTC Innovation Fund as it prepares to take its dry eye syndrome treatment through clinical testing.

University of Salford spinout Carbon Air has closed a funding round led by Mercia Fund Managers.

Existing shareholders have provided additional funding to Abingdon Health, which is developing a test for multiple myeloma.

ETH Zurich spinout Spirochem has raised cash to accelerate its sales activities and boost productivity.

The company is working on treatments for breast cancer and solid tumours, based on research at University of Toronto and the Centre for the Commercialization of Antibodies and Biologics.

Jay Hetzel has become chairman at Uniquest, bringing more than 20 years of life science and commercialisation expertise accrued at the Csiro research agency.

UT Horizon Fund has returned for a $7m series A for GenXComm, having also contributed to a $1.5m seed round in June this year.

University of Surrey in-video advertising spinout Mirriad is set to raise $35m in an initial public offering at a market cap of $84.4m.